GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioHarvest Sciences Inc (XCNQ:BHSC) » Definitions » Cash Conversion Cycle

BioHarvest Sciences (XCNQ:BHSC) Cash Conversion Cycle : -2.27 (As of Jun. 2024)


View and export this data going back to 2015. Start your Free Trial

What is BioHarvest Sciences Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

BioHarvest Sciences's Days Sales Outstanding for the three months ended in Jun. 2024 was 12.49.
BioHarvest Sciences's Days Inventory for the three months ended in Jun. 2024 was 81.27.
BioHarvest Sciences's Days Payable for the three months ended in Jun. 2024 was 96.03.
Therefore, BioHarvest Sciences's Cash Conversion Cycle (CCC) for the three months ended in Jun. 2024 was -2.27.


BioHarvest Sciences Cash Conversion Cycle Historical Data

The historical data trend for BioHarvest Sciences's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioHarvest Sciences Cash Conversion Cycle Chart

BioHarvest Sciences Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Dec20 Dec21 Dec22 Dec23
Cash Conversion Cycle
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 14.49 16.48 45.53 45.57

BioHarvest Sciences Quarterly Data
Jul19 Oct19 Jan20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.06 31.73 33.48 37.00 -2.27

Competitive Comparison of BioHarvest Sciences's Cash Conversion Cycle

For the Packaged Foods subindustry, BioHarvest Sciences's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioHarvest Sciences's Cash Conversion Cycle Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, BioHarvest Sciences's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where BioHarvest Sciences's Cash Conversion Cycle falls into.



BioHarvest Sciences Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

BioHarvest Sciences's Cash Conversion Cycle for the fiscal year that ended in Dec. 2023 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=19.58+100.1-74.11
=45.57

BioHarvest Sciences's Cash Conversion Cycle for the quarter that ended in Jun. 2024 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=12.49+81.27-96.03
=-2.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioHarvest Sciences  (XCNQ:BHSC) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


BioHarvest Sciences Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of BioHarvest Sciences's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


BioHarvest Sciences Business Description

Traded in Other Exchanges
Address
1140-625 Howe Street, Vancouver, BC, CAN, V6C 2T6
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

BioHarvest Sciences Headlines

No Headlines